| Literature DB >> 22525979 |
Y-Y Lee1, C-H Yang, C-H Chen, J-S Hwang.
Abstract
Strontium ranelate is an effective drug that was developed for treating osteoporosis. Here, we report the case of a 62-year-old woman who developed headache and diffuse scalp hair loss 1 week after receiving strontium ranelate treatment for osteoporosis. The treatment was subsequently stopped because of the intractable headache. Nevertheless, the patient continued to lose hair for 6 weeks following treatment discontinuation. Histopathological analysis of scalp tissues revealed anagen effluvium. The patient's hair started regrowing slowly 2 months after treatment with strontium ranelate was discontinued.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22525979 DOI： 10.1007/s00198-012-1979-9
Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507